TrueMed is the leading AI platform for counterfeit medication detection and intelligence. Headquartered in Espoo, Finland, with a US office in Palo Alto, TrueMed protects pharmaceutical brands, regulators and patients from substandard and falsified medicines. TrueMed’s patented technology is non-additive. It is the first authentication system that adds nothing to the product or its packaging: no stickers, no special inks, no hardware. A standard smartphone camera, tabletop scanner or any other digital image capture device is enough. Machine learning analyzes size and shape, colors, typography, print quality and micro-defects across pills, blister packs and cartons, then returns a result in seconds. The platform spans a consumer app for patients, a field app for investigators and customs officers, and a digital forensic lab that turns every scan into timestamped visual evidence for enforcement action.